We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients
2 min Read

Kronox Lab Sciences, a manufacturer of high-purity speciality fine chemicals, is set to launch its initial public offering (IPO) on June 3rd, 2024. This blog dives into the Kronox Lab Sciences IPO review, helping you decide if it aligns with your investment goals.

About Kronox Lab Sciences

  • Established Player: Founded in 2008, Kronox Lab Sciences boasts a rich experience in manufacturing speciality fine chemicals.
  • Diverse Product Portfolio: The company offers over 185 products catering to various industries like pharmaceuticals, nutraceuticals, and personal care.
  • Global Reach: They export to over 20 countries, including the US, UK, and China.
  • Manufacturing Strength: Kronox Lab Sciences has three well-equipped manufacturing facilities in Gujarat, close to major ports.
  • Focus on Innovation: Their ongoing research and development efforts aim to expand their product portfolio with 122 products currently under development.

Kronox Lab Sciences IPO fundamentals

Before you decide whether it is worth your IPO investment, let us have a look at the Kronox Lab Sciences IPO details.

  • Issue Type: Offer for Sale (OFS) - No fresh capital will be raised by the company
  • Issue Size: Rs 130.15 Crore
  • Price Band: Rs 129 - Rs 136 per share
  • Subscription Dates: June 3rd - June 5th, 2024
  • Listing: Expected on BSE & NSE by June 10th, 2024
  • Lot Size: Minimum 110 Shares (Rs 14,960 at cut-off price)

Kronox Lab Sciences financials

Let us have a look at the Kronox Lab Sciences financials as of March 31, 2023. Understanding the financials, revenue growth and profits tell us a lot about how the company is doing and is a crucial part of the Kronox Lab Sciences fundamentals too.

  • Revenue Growth: 16.99% increase compared to the previous year.
  • Profit Growth: 21.94% increase in Profit After Tax (PAT) compared to the previous year.

Things to consider before subscribing to the Kronox Lab Sciences IPO

  • Limited Financial Information: Since this is an OFS, the company isn't raising fresh capital, and there might be limited information available on future growth plans.
  • Market Risks: The speciality chemicals industry is subject to fluctuations in raw material prices and competition.
  • Dependence on Exports: A significant portion of their revenue comes from exports, making them vulnerable to currency fluctuations and global economic conditions.

Overall, Kronox Lab Sciences IPO presents an opportunity to invest in a growing speciality chemicals company with a global presence. However, carefully consider the risks involved and conduct thorough research before making an IPO investment decision.

Disclaimer: This blog is for informational purposes only and should not be considered financial advice. Please consult a qualified financial advisor before making any investment decisions.